Radiolabelled nanoparticles in cancer management

Current status and developments

Sumeet Suresh Malapure, Shivanand Bhushan, Rajesh Kumar, Sanjay Bharati

Research output: Contribution to journalShort survey

1 Citation (Scopus)

Abstract

The current concepts of cancer therapy are moving towards personalized treatment regimen aiming to improve efficacy and reduce toxicity of therapeutic agents. With the development of molecular imaging and targeted therapies, personalized care has received a shot in the arm. However, these developments are not without challenges. Drug delivery, metabolism, toxicity etc., challenge the effective utilization of such agents. Nanoparticles offer to overcome these hurdles with their unique physico-chemical properties. These particles can be labelled with radionuclides and conjugated with ligands to achieve high specific activity in the intended areas. In this article, we discuss the present status of radiolabelled nanoparticles, the areas where they are being used and challenges that lie ahead. We intend to provide a basic outlook on the utilization of radiolabelled nanoparticles in cancer diagnosis and therapy.

Original languageEnglish
Pages (from-to)25-34
Number of pages10
JournalChemical Biology Letters
Volume5
Issue number1
Publication statusPublished - 01-01-2018

Fingerprint

Nanoparticles
Toxicity
Molecular imaging
Neoplasms
Molecular Targeted Therapy
Drug delivery
Metabolism
Radioisotopes
Chemical properties
Molecular Imaging
Therapeutics
Ligands
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Malapure, Sumeet Suresh ; Bhushan, Shivanand ; Kumar, Rajesh ; Bharati, Sanjay. / Radiolabelled nanoparticles in cancer management : Current status and developments. In: Chemical Biology Letters. 2018 ; Vol. 5, No. 1. pp. 25-34.
@article{fd3ec75503d64234909296944b8c6adb,
title = "Radiolabelled nanoparticles in cancer management: Current status and developments",
abstract = "The current concepts of cancer therapy are moving towards personalized treatment regimen aiming to improve efficacy and reduce toxicity of therapeutic agents. With the development of molecular imaging and targeted therapies, personalized care has received a shot in the arm. However, these developments are not without challenges. Drug delivery, metabolism, toxicity etc., challenge the effective utilization of such agents. Nanoparticles offer to overcome these hurdles with their unique physico-chemical properties. These particles can be labelled with radionuclides and conjugated with ligands to achieve high specific activity in the intended areas. In this article, we discuss the present status of radiolabelled nanoparticles, the areas where they are being used and challenges that lie ahead. We intend to provide a basic outlook on the utilization of radiolabelled nanoparticles in cancer diagnosis and therapy.",
author = "Malapure, {Sumeet Suresh} and Shivanand Bhushan and Rajesh Kumar and Sanjay Bharati",
year = "2018",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "25--34",
journal = "Chemical Biology Letters",
issn = "2347-9825",
publisher = "Integrated Science Publishing",
number = "1",

}

Radiolabelled nanoparticles in cancer management : Current status and developments. / Malapure, Sumeet Suresh; Bhushan, Shivanand; Kumar, Rajesh; Bharati, Sanjay.

In: Chemical Biology Letters, Vol. 5, No. 1, 01.01.2018, p. 25-34.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Radiolabelled nanoparticles in cancer management

T2 - Current status and developments

AU - Malapure, Sumeet Suresh

AU - Bhushan, Shivanand

AU - Kumar, Rajesh

AU - Bharati, Sanjay

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The current concepts of cancer therapy are moving towards personalized treatment regimen aiming to improve efficacy and reduce toxicity of therapeutic agents. With the development of molecular imaging and targeted therapies, personalized care has received a shot in the arm. However, these developments are not without challenges. Drug delivery, metabolism, toxicity etc., challenge the effective utilization of such agents. Nanoparticles offer to overcome these hurdles with their unique physico-chemical properties. These particles can be labelled with radionuclides and conjugated with ligands to achieve high specific activity in the intended areas. In this article, we discuss the present status of radiolabelled nanoparticles, the areas where they are being used and challenges that lie ahead. We intend to provide a basic outlook on the utilization of radiolabelled nanoparticles in cancer diagnosis and therapy.

AB - The current concepts of cancer therapy are moving towards personalized treatment regimen aiming to improve efficacy and reduce toxicity of therapeutic agents. With the development of molecular imaging and targeted therapies, personalized care has received a shot in the arm. However, these developments are not without challenges. Drug delivery, metabolism, toxicity etc., challenge the effective utilization of such agents. Nanoparticles offer to overcome these hurdles with their unique physico-chemical properties. These particles can be labelled with radionuclides and conjugated with ligands to achieve high specific activity in the intended areas. In this article, we discuss the present status of radiolabelled nanoparticles, the areas where they are being used and challenges that lie ahead. We intend to provide a basic outlook on the utilization of radiolabelled nanoparticles in cancer diagnosis and therapy.

UR - http://www.scopus.com/inward/record.url?scp=85046645064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046645064&partnerID=8YFLogxK

M3 - Short survey

VL - 5

SP - 25

EP - 34

JO - Chemical Biology Letters

JF - Chemical Biology Letters

SN - 2347-9825

IS - 1

ER -